However, targeting miR-25 induced E-cadherin expression and suppressed EMT, and targeting of E-cadherin in cancer cells could be sufficient to reverse EMT in anti-miR-25 treated cells, which was accompanied by a more invasive property. Here, CDH1 is linked to cancer.